Article Listing - Vitamin A can cut infant death risk in LDCs 15%

STOCK MARKET COMMENTARY: EUROPE

13 April 1992

EUROPE: seemed to be impacted in many areas by elections of one sort or another. Despite earlier worries, FRANKFURT seemed...

PHARMA ECONOMICS' "SEVEN DEADLY SINS"

13 April 1992

Concerns about economic evaluation of new drug products have been likened to the seven deadly sins by Michael Drummond of...

CERVOXAN 60mg LAUNCHED IN FRANCE

13 April 1992

Laboratoires Sobio, which is part of SmithKline Beecham, has launched a new 60mg oral formulation of Cervoxan (vinburnine) its cerebral/peripheral...

US RESISTANCE TO DRUG PRICE RISES

13 April 1992

The US pharmaceutical industry will continue to face growing resistance from the federal government and also from private forces towards...

EXPANSION AT SILESIA IN CHILE

13 April 1992

The Chilean pharmaceutical comp-any Silesia is continuing to expand at is base in Santiago. The company its currently working on...

ROCHE'S LAZABEMIDE IN PHASE III NEXT YEAR

13 April 1992

Hoffmann-La Roche has indicated that it expects to begin Phase III trials with its mono-amine oxidase type B-selective inhibitor lazabemide...

ROCHE'S LOCERYL LAUNCHED IN FRANCE

13 April 1992

Roche Produits, a subsidiary of Hoffmann-La Roche, has introduced its nail lacquer antifungal product Loceryl (amorolfine). This is the first...

SAFER TRAVELLER'S DIARRHEA DRUG

13 April 1992

A safer treatment for traveller's diarrhea may soon be available, which will be suitable for use by adults, children and...

EPIC REGISTRATION NOW OVER 1,300

6 April 1992

Speaking at the 12th International Symposium on Intensive Care and Emergency Medicine in Brussels, late last month, Andre Heyns, Roussel-...

INTERFERON ALFA-N3 AND AIDS

6 April 1992

Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...

Showing 94371-94380 of 95353 articles

Go to beginningPreviousNextGo to end